LLY Competitors & Alternatives
Compare Eli Lilly and Company with similar stocks in the same industry
Drug Manufacturers - General
LLY
Main Stock$1181.87
Tradestie Score
58
Market Cap
$739.95B
P/E Ratio
42.2
Revenue Growth
0.6%
Analyst Upside
+5.0%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVGO
Broadcom Inc. Common Stock
|
$384.05
|
$1.57T | 66.7 | 55 | Compare |
|
JNJ
Johnson & Johnson
|
$257.77
|
$448.07B | 29.8 | 58 | Compare |
|
ABBV
ABBVIE INC.
|
$248.00
|
$431.71B | 122.2 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$49.28
|
$262.92B | 11.9 | 64 | Compare |
|
AZN
AstraZeneca PLC
|
$169.47
|
$261.56B | 25.8 | 51 | Compare |
|
NVS
Novartis AG
|
$153.37
|
$254.99B | 22.1 | 49 | Compare |
|
ABT
Abbott Laboratories
|
$92.11
|
$232.30B | 26.3 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$124.03
|
$225.13B | 34.8 | 59 | Compare |
|
AMGN
Amgen Inc
|
$360.45
|
$160.70B | 25.3 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$24.48
|
$154.70B | 18.5 | 56 | Compare |
More LLY Analysis
Data updated: Jul 13, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry